-
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
- Sang Heon Han, Hyeong Dong Yuk
-
J Urol Oncol. 2023;21(1):32-44.
-
Original Article
Mar 31, 2023
The Landscape of Epidemiology in Urologic Cancers
|
-
Complex Epidemiology of Prostate Cancer in Asian Countries
- Kagenori Ito, Takahiro Kimura
-
J Urol Oncol. 2023;21(1):5-13.
-
Review Article
Mar 31, 2023
|
-
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
- Sang Hun Song, Jong Jin Oh
-
J Urol Oncol. 2023;21(2):154-164.
-
Invited Review
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|
-
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
- Chang Wook Jeong
-
J Urol Oncol. 2024;22(1):4-10.
-
Invited Review
Mar 31, 2024
Prostate Cancer
|
-
A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening
- Jung Sik Huh, Kyung Kgi Park
-
J Urol Oncol. 2023;21(2):121-127.
-
Original Article
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
The Predictive Value of the Preoperative Systemic Inflammatory Response Indices in Non–Organ-Confined Disease in Upper Urinary Tract Urothelial Carcinoma
- Sung Kyung Choi, Chan Hoon Gwak, Jungyo Suh, et al.
-
J Urol Oncol. 2023;21(2):174-180.
-
Original Article
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|
-
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
- Byung Kwan Park
-
J Urol Oncol. 2023;21(2):106-111.
-
Invited Review
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma
- Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, et al.
-
J Urol Oncol. 2023;21(3):183-199.
-
Invited Review
Nov 30, 2023
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
|
-
Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
- Chan Woo Wee, Jaeho Cho
-
J Urol Oncol. 2023;21(3):217-227.
-
Invited Review
Nov 30, 2023
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
|
-
Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
- Jiwoong Yu, Hyun Hwan Sung
-
J Urol Oncol. 2023;21(3):228-240.
-
Invited Review
Nov 30, 2023
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
|
-
Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis
- Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, et al.
-
J Urol Oncol. 2024;22(1):34-41.
-
Systemic Review and Meta-analysis
Mar 31, 2024
Kidney Cancer
|
-
Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
- Jung Hoon Kim, Ji Woong Hwang
-
J Urol Oncol. 2024;22(1):42-51.
-
Original Article
Mar 31, 2024
Kidney Cancer
|
-
The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies
- Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, et al.
-
J Urol Oncol. 2023;21(1):23-31.
-
Review Article
Mar 31, 2023
|
-
Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database
- Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, et al.
-
J Urol Oncol. 2023;21(1):45-52.
-
Original Article
Mar 31, 2023
|
-
Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey
- Joongwon Choi, Cheryn Song, Jungyo Suh, et al.
-
J Urol Oncol. 2023;21(1):59-69.
-
Original Article
Mar 31, 2023
|
-
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
- Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, et al.
-
J Urol Oncol. 2023;21(1):70-78.
-
Original Article
Mar 31, 2023
|
-
The Prognostic Significance of Body Mass Index in Patients Undergoing Nephrectomy for Nonmetastatic Renal Cell Carcinoma
- Hee Jae Yoo, Sun Il Kim, Se Joong Kim, et al.
-
J Urol Oncol. 2023;21(1):88-94.
-
Original Article
Mar 31, 2023
|
-
Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery?
- Ja Yoon Ku, Hui Mo Gu, Seong Hyeon Yu, et al.
-
J Urol Oncol. 2023;21(2):140-147.
-
Invited Review
Jul 31, 2023
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
|
-
The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance
- Chang Wook Jeong
-
J Urol Oncol. 2023;21(2):97-105.
-
Invited Review
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma
- Dongsu Kim, Bumjin Lim, Jungyo Suh, et al.
-
J Urol Oncol. 2023;21(2):148-153.
-
Original Article
Jul 31, 2023
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
|
-
Impact of Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Extension According to the National Comprehensive Cancer Network Risk Stratification in Prostate Cancer
- Jae Hoon Kang, Jun-Koo Kang, Jae-Wook Chung, et al.
-
J Urol Oncol. 2023;21(2):112-120.
-
Topic Article
Jul 31, 2023
mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness
|
-
Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis
- Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, et al.
-
J Urol Oncol. 2023;21(2):165-173.
-
Original Article
Jul 31, 2023
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
|
-
Genetic Testing for Prostate Cancer, Urothelial Cancer, and Kidney Cancer
- Hyunho Han, Minyong Kang, Seok-Soo Byun, et al.
-
J Urol Oncol. 2023;21(2):128-139.
-
Invited Review
Jul 31, 2023
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
|
-
Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis
- Jin Noh, Sang Hun Song, Gyoohwan Jung, et al.
-
J Urol Oncol. 2023;21(3):200-207.
-
Topic Article
Nov 30, 2023
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
|
-
The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects
- Hyerim Ha, Joo Han Lim
-
J Urol Oncol. 2023;21(3):208-216.
-
Invited Review
Nov 30, 2023
Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma
|
-
Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy
- Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al.
-
J Urol Oncol. 2023;21(3):249-256.Correction in: 2024;22(2):183
-
Original Article
Nov 30, 2023
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
|
-
Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
- Jaeyoung Cho, Jungyo Suh, Dalsan You, et al.
-
J Urol Oncol. 2023;21(3):257-263.
-
Topic Article
Nov 30, 2023
Clinical Predictors of ARTA Response in Metastatic Prostate Cancer
|
-
Nonregional Lymph Node Metastasis as a Predictor of Early Progression When Using Androgen Receptor Targeting Agents in Patients With Metastatic Castration-Resistant Prostate Cancer Without Previous Chemotherapy
- Sihyeon Kim, Beom Yong Rho, Dong Hyuk Kang, et al.
-
J Urol Oncol. 2023;21(3):264-270.
-
Topic Article
Nov 30, 2023
Clinical Predictors of ARTA Response in Metastatic Prostate Cancer
|
-
Negative Delta-Prostate-Specific Antigen Time Ratio as Potential New Marker of Progression-Free Survival in Castration-Resistant Prostate Cancer Patients Treated With First-Line Enzalutamide or Docetaxel
- Tae Hwan Kim, Seol Ho Choo, Kang Hee Shim, et al.
-
J Urol Oncol. 2023;21(3):271-276.
-
Original Article
Nov 30, 2023
Clinical Predictors of ARTA Response in Metastatic Prostate Cancer
|
-
Early Experience With Pembrolizumab in Bacillus Calmette-Guérin Unresponsive Non–Muscle-Invasive Bladder Cancer
- Chung Un Lee, Wan Song, Minyong Kang, et al.
-
J Urol Oncol. 2023;21(3):241-248.
-
Topic Article
Nov 30, 2023
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
|